Eagle's Eye View: Your Weekly CV Update From ACC.org

Eagle’s Eye View: NOAC vs. Warfarin For AFib, Sex Disparities in Medical-Guided Therapy Among HFrEF Patients, Polygenic Risk in Families With Spontaneous SCAD

01.31.2024 - By American College of CardiologyPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

In this week’s View, Dr. Eagle discusses the use of non–Vitamin-K antagonist oral anticoagulants versus warfarin across the spectrum of body mass index and weight. He then explores sex disparities in longitudinal use and intensification of guideline-directed medical therapy among patients with newly diagnosed heart failure with reduced ejection fraction. Finally, Dr. Eagle talks about polygenic risk in families with spontaneous coronary artery dissection.  Subscribe to Eagle’s Eye View  

More episodes from Eagle's Eye View: Your Weekly CV Update From ACC.org